Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

NCT02582320 ·Status: COMPLETED

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

NCT06125795 ·Status: ACTIVE_NOT_RECRUITING

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

NCT00535873 ·Status: COMPLETED ·Phase: PHASE2

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

NCT00419250 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

NCT03971565 ·Status: UNKNOWN

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

NCT01649791 ·Status: TERMINATED ·Phase: NA

LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION

NCT07313982 ·Status: RECRUITING

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

NCT01368757 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

NCT01862445 ·Status: UNKNOWN

Association of CD49d and CD44 in CLL Patients and Their Role in Prognosis

NCT03380299 ·Status: UNKNOWN

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL

NCT02758665 ·Status: COMPLETED ·Phase: PHASE2

the Real World Study of Orelabrutinib in the Treatment of CLL/SLL

NCT05975164 ·Status: UNKNOWN

Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia

NCT02020109 ·Status: WITHDRAWN

Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia

NCT06814444 ·Status: RECRUITING

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

NCT07337967 ·Status: NOT_YET_RECRUITING

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia

NCT00714103 ·Status: COMPLETED ·Phase: PHASE1

Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).

NCT01282593 ·Status: COMPLETED ·Phase: NA

Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO)

NCT05517265 ·Status: COMPLETED

Observational Study in CLL Patients Receiving BR

NCT02381899 ·Status: COMPLETED

"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

NCT06919393 ·Status: RECRUITING

Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL

NCT01703364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)

NCT01403246 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

NCT03075969 ·Status: UNKNOWN

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

NCT07189117 ·Status: RECRUITING

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

NCT05605379 ·Status: RECRUITING